Company News

Share this article:

AstraZeneca (AZ) announced a partnership with Astellas Pharma to co-promote AZ's Symbicort Turbuhaler in Japan. Astellas will make an upfront payment of $31.5 million to AZ, plus additional milestone payments depending on sales.

inVentiv Health announced the addition of a Japanese office in Tokyo – inVentiv Japan – to be led by Dan Feldman. The office will provide outsourced sales solutions and communications in the pharmaceutical and healthcare space, according to a release.


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.